To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer
Clinical trial NCT01496313 · COMPLETED
Trial details
- NCT number
- NCT01496313
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2012-06-08
- Primary completion
- 2014-04-02
- Enrollment
- 81
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.